|TASEBM -- Israel Index|| |
ILS 359.38 2.12 0.59%
The entity owns Beta (Systematic Risk) of 0.0 which indicates the returns on MARKET and TA Biomed are completely uncorrelated. Although it is extremely important to respect TA Biomed
existing price patterns
, it is better to be realistic regarding the information on equity price patterns
. The way in which we are measuring future performance of any index is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators
. By examining TA Biomed technical indicators
you can at this moment evaluate if the expected return of 0.0% will be sustainable into the future.
TA Biomed Relative Risk vs. Return Landscape
If you would invest 35,938
in TA Biomed on November 12, 2018
and sell it today you would earn a total of 0.00
from holding TA Biomed or generate 0.0%
return on investment over 30
days. TA Biomed is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than TA Biomed and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
Daily Expected Return (%)
TA Biomed Market Risk Analysis
Sharpe Ratio = 0.0
Based on monthly moving average TA Biomed is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TA Biomed
by adding it to a well-diversified
|TA Biomed is not yet fully synchronised with the market data|
Also please take a look at World Market Map
. Please also try Price Transformation
module to use price transformation models to analyze depth of different equity instruments across global markets.